Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α‐Positive Advanced Ovarian Cancer

ABSTRACT Background Folate receptor α (FRα) is a glycosylphosphatidylinositol‐anchored protein that facilitates folate transport and has emerged as a promising therapeutic target for ovarian cancer, particularly due to its association with tumor progression. This Phase I study investigated the safet...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yongsheng Li, Li Yuan, Ge Lou, Hongbing Cai, Yuzhi Li, Fenghu Li, Li Wang, Xingtao Long, Yi Gong, Chaonan Zhu, Li Li, June Xu, Qi Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-05-01
coleção:	Cancer Medicine
Assuntos:	antibody drug conjugate mirvetuximab soravtansine refractory ovarian cancer targeted therapy
Acesso em linha:	https://doi.org/10.1002/cam4.71704
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!